Spectra Plasmonics
Kingston
About Spectra Plasmonics
Spectra Plasmonics provides portable technology that offers chemical sensing products. Their core technology is Amplifi ID, which enables chemical analysis without complex lab steps. It offers an optimal, high-performance drug checking solution. They provide software that generates a report for each scanned drug about the detected sample contents.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $107.9K
- Last round: Grant (Apr 2025)
- Website: spectraplasmonics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Nanotechnology
Social Profiles
Canonical: https://fsome.com/organization/spectra-plasmonics-127355 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.